Shifts In Protein Aggregate Stability Define Proteostasis Decline In The Aging Human Brain
As we age, our brains undergo many changes, and one crucial process is how our cells manage their proteins. This management system, called proteostasis (protein homeostasis), ensures that proteins are correctly made, folded, and cleared away when they are no longer needed. When this system falters, proteins can misfold and clump together, forming what are known as protein aggregates. These aggregates are a hallmark of aging and are commonly found in neurodegenerative diseases like Alzheimer’s.
Recent research has shed new light on how these protein aggregates change in the human brain as we get older. Scientists used a technique called detergent-fractionation proteomics, which helps separate proteins based on how easily they dissolve, to study the “insoluble proteome” – the collection of proteins that have clumped together.
Contrary to the idea that all protein aggregates simply increase with age, this study found a more complex picture. It revealed that brain aging doesn’t involve a uniform buildup of these clumps. Instead, the insoluble proteome undergoes a significant “remodeling” starting in midlife. Specifically, the most stable protein aggregates actually decrease sharply in old age. At the same time, aggregates with intermediate stability progressively accumulate, with their buildup accelerating significantly after age 80.
These intermediate-stability aggregates are particularly interesting because they are prone to a process called liquid-liquid phase separation, where molecules separate into distinct liquid compartments within the cell. Importantly, these types of aggregates are also enriched in the plaques and tangles characteristic of Alzheimer’s disease.
The study also highlighted the importance of the cell’s protein quality control machinery. The capacity of proteasomes (cellular machines that break down old or damaged proteins) and cytosolic chaperones (proteins that help other proteins fold correctly) were found to predict an individual’s aggregate burden as strongly as their chronological age.
These findings suggest that the way protein aggregates change in stability is a key feature of normal brain aging. The accumulation of these intermediate-stability aggregates could be a critical molecular step on the path to neurodegenerative diseases. This understanding could pave the way for new therapies that target these specific protein management pathways to promote healthier brain aging.
Source: link to paper